CoreCap Advisors
MRNA icon

CoreCap Advisors’s Moderna MRNA Stock Holding History

CoreCap Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$640K Sell
3,324
-1,271
-28% -$137K 0.02% 489
2026
Q2 		$322K Buy
4,595
+3,931
+592% +$203K 0.01% 691
2026
Q1 		$33.7K Buy
664
+139
+26% +$6.48K ﹤0.01% 1475
2025
Q4 		$15.5K Sell
525
-700
-57% -$19K ﹤0.01% 1788
2025
Q3 		$31.6K Sell
1,225
-10
-0.8% -$279 ﹤0.01% 1496
2025
Q2 		$34.1K Buy
1,235
+121
+11% +$3.19K ﹤0.01% 1405
2025
Q1 		$31.6K Sell
1,114
-4
-0.4% -$142 ﹤0.01% 1362
2024
Q4 		$46.5K Sell
1,118
-98
-8% -$4.68K ﹤0.01% 1210
2024
Q3 		$81.3K Buy
1,216
+28
+2% +$2.57K ﹤0.01% 1003
2024
Q2 		$141K Buy
1,188
+16
+1% +$2.02K 0.01% 429
2024
Q1 		$125K Buy
+1,172
New +$118K 0.01% 769
2022
Q4 		$387K Buy
+2,155
New +$352K 0.03% 399
2022
Q3 		– Sell
-1,797
Closed -$257K – 1482
2022
Q2 		$257K Buy
+1,797
New +$257K 0.02% 453
2022
Q1 		– Sell
-859
Closed -$218K – 1475
2021
Q4 		$218K Buy
+859
New +$251K 0.01% 516

Other funds holding MRNA

Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Beau Ventures, LLc
Beau Ventures, LLc Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
LAI
Legal Advantage Investments Los Altos Hills, California $468M AUM 7.83% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

CoreCap Advisors's MRNA Position: Q3 2026 in Review

CoreCap Advisors reduced its Moderna (MRNA) stake by 28% in Q3 2026, selling an estimated $137K and leaving 3,324 shares worth $640K. The position accounts for 0.02% of the portfolio, ranked #489.

CoreCap Advisors first reported a position in MRNA in Q4 2021 and has held it in 14 quarters since. 198 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • CoreCap Advisors held 3,324 shares of Moderna worth $640K as of Q3 2026.
  • CoreCap Advisors sold 1,271 Moderna shares in Q3 2026, an estimated $137K.
  • Moderna made up 0.02% of CoreCap Advisors's portfolio in Q3 2026, its #489 holding.
  • CoreCap Advisors first reported a position in Moderna in Q4 2021 and has held it in 14 quarters since.
  • 198 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.